Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Witkin

Showing results (291-300 of 321) with videos related to

Pageof 33
Sort By:
Neuropharmacology|August 1, 2017
Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptorsJeffrey M Witkin, Jennifer Li, Gary Gilmour, et al.
ARKIVOC : Free Online Journal of Organic Chemistry|May 22, 2024
An efficient debromination technique using PMHS with a number of ligands containing different functional groupsMd Yeunus Mian, Prithu Mondal, Dishary Sharmin, et al.
CNS & Neurological Disorders Drug Targets|November 2, 2017
Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)Jeffrey M Witkin, Douglas A Schober, Scott D Gleason, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2015
A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating DisorderMichael A Statnick, Yanyun Chen, Michael Ansonoff, et al.
Psychopharmacology|January 28, 2018
Negative allosteric modulation of alpha 5-containing GABA<sub>A</sub> receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing miceNina Z Xu, Margot Ernst, Marco Treven, et al.
ACS Chemical Neuroscience|August 14, 2020
Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure EffectsDaniel E Knutson, Jodi L Smith, Xingjie Ping, et al.
Biochemical Pharmacology|June 26, 2018
Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studiesJeffrey M Witkin, Ryan A Shenvi, Xia Li, et al.
Pharmacology, Biochemistry, and Behavior|May 2, 2018
An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptorsK R Methuku, X Li, R Cerne, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2017
Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effectsJ M Witkin, J A Monn, J Li, et al.
ARKIVOC : Free Online Journal of Organic Chemistry|March 1, 2021
Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligandsKamal P Pandey, Zubair Ahmed Khan, Lalit K Golani, et al.
Pageof 33

Showing results (291-300 of 321) with videos related to

Sort By:
Pageof 33
Neuropharmacology|August 1, 2017
Electroencephalographic, cognitive, and neurochemical effects of LY3130481 (CERC-611), a selective antagonist of TARP-γ8-associated AMPA receptorsJeffrey M Witkin, Jennifer Li, Gary Gilmour, et al.
ARKIVOC : Free Online Journal of Organic Chemistry|May 22, 2024
An efficient debromination technique using PMHS with a number of ligands containing different functional groupsMd Yeunus Mian, Prithu Mondal, Dishary Sharmin, et al.
CNS & Neurological Disorders Drug Targets|November 2, 2017
Targeted Blockade of TARP-γ8-Associated AMPA Receptors: Anticonvulsant Activity with the Selective Antagonist LY3130481 (CERC-611)Jeffrey M Witkin, Douglas A Schober, Scott D Gleason, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 15, 2015
A Novel Nociceptin Receptor Antagonist LY2940094 Inhibits Excessive Feeding Behavior in Rodents: A Possible Mechanism for the Treatment of Binge Eating DisorderMichael A Statnick, Yanyun Chen, Michael Ansonoff, et al.
Psychopharmacology|January 28, 2018
Negative allosteric modulation of alpha 5-containing GABA<sub>A</sub> receptors engenders antidepressant-like effects and selectively prevents age-associated hyperactivity in tau-depositing miceNina Z Xu, Margot Ernst, Marco Treven, et al.
ACS Chemical Neuroscience|August 14, 2020
Imidazodiazepine Anticonvulsant, KRM-II-81, Produces Novel, Non-diazepam-like Antiseizure EffectsDaniel E Knutson, Jodi L Smith, Xingjie Ping, et al.
Biochemical Pharmacology|June 26, 2018
Pharmacological characterization of the neurotrophic sesquiterpene jiadifenolide reveals a non-convulsant signature and potential for progression in neurodegenerative disease studiesJeffrey M Witkin, Ryan A Shenvi, Xia Li, et al.
Pharmacology, Biochemistry, and Behavior|May 2, 2018
An antidepressant-related pharmacological signature for positive allosteric modulators of α2/3-containing GABA<sub>A</sub> receptorsK R Methuku, X Li, R Cerne, et al.
Pharmacology, Biochemistry, and Behavior|March 13, 2017
Preclinical predictors that the orthosteric mGlu2/3 receptor antagonist LY3020371 will not engender ketamine-associated neurotoxic, motor, cognitive, subjective, or abuse-liability-related effectsJ M Witkin, J A Monn, J Li, et al.
ARKIVOC : Free Online Journal of Organic Chemistry|March 1, 2021
Design, synthesis and characterization of novel gamma‑aminobutyric acid type A receptor ligandsKamal P Pandey, Zubair Ahmed Khan, Lalit K Golani, et al.
Pageof 33